Literature DB >> 22981298

When does Parkinson's disease begin? From prodromal disease to motor signs.

W G Meissner1.   

Abstract

Cardinal motor features of Parkinson's disease (PD) appear when about half of the nigral dopamine neurons have disappeared. Based on extrapolations from post-mortem and imaging studies, the delay between the onset of dopamine denervation and the appearance of motor signs ranges from 5 to 20years. According to Braak and co-workers, motor symptoms only appear at stage III of PD, while the neurodegenerative process begins earlier in the olfactory bulb and lower brain stem. In addition to the cardinal motor features, non-motor signs are increasingly being recognized in PD. Some of them, mainly olfactory disturbances, rapid-eye-movement sleep behaviour disorder and autonomic dysfunction, are already present in the early disease stages and may precede the onset of motor signs by up to four decades. These non-motor signs are related to widespread extranigral and even extracerebral degeneration, and have been considered risk factors for many years. Indeed, recent evidence suggests that they may be prodromal manifestations of PD. From the perspective of future disease-modifying or neuroprotective treatments, combining prodromal non-motor signs and paraclinical investigations may help to further develop reliable tools for early diagnosis of PD before the onset of its cardinal motor features.
Copyright © 2012. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2012        PMID: 22981298     DOI: 10.1016/j.neurol.2012.07.004

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  16 in total

1.  Multisystem Lewy body disease and the other parkinsonian disorders.

Authors:  J William Langston; Birgitt Schüle; Linda Rees; R Jeremy Nichols; Carrolee Barlow
Journal:  Nat Genet       Date:  2015-12       Impact factor: 38.330

2.  Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Authors:  Athanasios D Spathis; Xenophon Asvos; Despina Ziavra; Theodoros Karampelas; Stavros Topouzis; Zoe Cournia; Xiaobing Qing; Pavlos Alexakos; Lisa M Smits; Christina Dalla; Hardy J Rideout; Jens Christian Schwamborn; Constantin Tamvakopoulos; Demosthenes Fokas; Demetrios K Vassilatis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

3.  Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene.

Authors:  Anat Mirelman; Roy N Alcalay; Rachel Saunders-Pullman; Kira Yasinovsky; Avner Thaler; Tanya Gurevich; Helen Mejia-Santana; Deborah Raymond; Mali Gana-Weisz; Anat Bar-Shira; Laurie Ozelius; Lorraine Clark; Avi Orr-Urtreger; Susan Bressman; Karen Marder; Nir Giladi
Journal:  Mov Disord       Date:  2015-03-21       Impact factor: 10.338

4.  Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.

Authors:  Renata Pietsch Ribeiro; Eduardo Luiz Gasnhar Moreira; Danúbia Bonfanti Santos; Dirleise Colle; Alessandra Antunes Dos Santos; Kaite Cristiane Peres; Claudia Pinto Figueiredo; Marcelo Farina
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

5.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

6.  Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.

Authors:  M J Lelos; R J Morgan; C M Kelly; E M Torres; A E Rosser; S B Dunnett
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

7.  Engaging cognitive circuits to promote motor recovery in degenerative disorders. exercise as a learning modality.

Authors:  Michael W Jakowec; Zhou Wang; Daniel Holschneider; Jeff Beeler; Giselle M Petzinger
Journal:  J Hum Kinet       Date:  2016-09-10       Impact factor: 2.193

Review 8.  Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.

Authors:  Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Antonieta Mora-Tiscareño; Humberto Medina-Cortina; Ricardo Torres-Jardón; Michael Kavanaugh
Journal:  Biomed Res Int       Date:  2013-02-07       Impact factor: 3.411

9.  REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.

Authors:  Abhimanyu Mahajan; Liana S Rosenthal; Charlene Gamaldo; Rachel E Salas; Gregory M Pontone; Arita McCoy; Chizoba Umeh; Zoltan Mari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-06-23

10.  Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials.

Authors:  Fan Xu; Wenbin Ma; Yongmin Huang; Zhihai Qiu; Lei Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-22       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.